Sadie studied biotech at UNSW and worked in vaccine research before pivoting to healthtech commercialization. She founded her biotech venture focused on developing diagnostic assays for rare genetic disorders. Her startup has received grant funding from the ANU Centre for Applied Medical Research and is now preparing for first clinical trials.